https://www.selleckchem.com/EGFR(HER).html
Pre-clinical studies are underway with induced pluripotent stem cells, endothelial stem cell regeneration, gene therapy, anti-sense oligonucleotides, and various biologic/pharmacologic approaches designed to treat, prevent, or retard corneal endothelial dysfunction. The availability of more therapeutic options will hopefully expand access around the world while also allowing treatment to be more precisely tailored to each individual patient.Cataract, a clouding of the lens, is the most common cause of blindness in the world. It has a marked im
Like
Comment
Share
